2 growth stocks I'd buy with $5,000 today

Challenger Ltd (ASX:CGF) and NIB Holdings Limited (ASX:NHF) are two growth stocks I'd want to buy today.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There aren't many businesses on the ASX that deliver strong profit growth and dividend growth year after year.

When you find one of these businesses it's a good idea to buy and hold for the long-term growth and let the dividends roll in.

Past performance is not an indicator of future performance of course, but I think these two businesses have strong futures ahead:

Challenger Ltd (ASX: CGF)

Challenger is Australia's leading annuity business with a market capitalisation of $7.32 billion. Challenger is reporting tremendous growth in its annuity sales, in the six months to 31 December 2016 it reported annuity sales grew by 32% compared to the prior corresponding period.

There is a great opportunity for Challenger over the years ahead because the number of over 65s is expected to grow by 75% over the next 20 years, this is Challenger's target market.

Management are doing a great job of increasing Challenger's distribution channels to increase sales. In FY17 it has added entities like Suncorp Group Ltd (ASX: SUN) and CareSuper to its distribution channels. In FY18 it's scheduled to add AMP Limited (ASX: AMP) and BT Investment Management Ltd (ASX: BTT) to its growing list.

There is a strong possibility that the government may decide that a certain portion of an Australian's retirement assets need to be turned into an income-producing product, which Challenger could provide.

Challenger is currently trading at 19x FY17's estimated earnings with a grossed-up dividend yield of 3.74%.

NIB Holdings Limited (ASX: NHF)

NIB Holdings is one of Australia's largest private health insurers with a market capitalisation of $2.63 billion.

Private health insurance is a contentious issue for some, as it grows more expensive every year and this is putting some people off with how expensive it is.

However, NIB manages to keep growing its total number of policyholders. In the 12 months from 31 December 2015 to 31 December 2016 it grew its total policyholders from 706,226 to 751,629. This is a good performance from NIB compared to rival Medibank Private Ltd (ASX: MPL).

The government needs the private health insurance industry to succeed so that it takes pressure off the public health system which will become increasingly unaffordable if trying to provide the current level of care. Therefore, I think NIB will be able to keep growing profit in the long-term.

NIB is trading at 22x FY17's estimated earnings with a grossed-up dividend yield of 4.17%.

Foolish takeaway

I think both of these businesses will be strong long-term performers for shareholders and are worth a place in any Foolish portfolio.

Motley Fool contributor Tristan Harrison owns shares of Challenger Limited. The Motley Fool Australia owns shares of Challenger Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »